About Life Line Biotech Limited
Data last updated:
Life Line Biotech Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 August 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL1986PLC025119. Its GSTIN is 07AAACL1154F1ZY (Delhi). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1.6 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Satish Agarwal (Managing Director) and Santosh Agarwal (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 51 Dsiidc Shed Okhla Industrial Area Phase – II New Delhi – 110020, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.14 Cr, a decline of 66% compared to the previous year. For the same year it recorded a net profit of ₹7,524 (net margin 0.1%) and EBITDA of ₹77,434 (EBITDA margin 0.7%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 19% over five years.
As per MCA filings, the company has satisfied charges of ₹5.7 Cr on record. Court records list 22 cases involving the company, including 7 filed by the company and 15 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lifelinebiotech.com.
Company details
Contact details
Life Line Biotech Limited's registered office is in New Delhi, Delhi. Its website is lifelinebiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address51 Dsiidc Shed Okhla Industrial Area Phase – II New Delhi – 110020, Delhi, India – 110020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Life Line Biotech Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Life Line Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Life Line Biotech Limited, buy the company report.
Financials of Life Line Biotech Limited
FY 2025 filings availableLife Line Biotech Limited reported revenue of ₹1.14 Cr (down 66% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 66% fall in the latest year. EBITDA fell 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹77,434 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,524 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Life Line Biotech Limited, buy the company report.
Board of directors of Life Line Biotech Limited
Life Line Biotech has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Agarwal | Managing Director | 30 Sep 2003 | 23 Years 1 Months | Current |
| Kapil Sharma | Director | 01 Sep 2016 | 10 Years 2 Months | Current |
| Santosh Agarwal | Whole-Time Director | 12 Nov 2008 | 17 Years 11 Months | Current |
Peer comparison
Life Line Biotech Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Osr Pharmaceuticals Private Limited | ₹1.14 Cr (FY 2025) | 11.0% | Delhi, India | |||
| Pyramid Formulations Private Limited | ₹1.14 Cr (FY 2023) | 16.0% | Salem, Tamil Nadu, India | |||
| Life Line Biotech Limitedthis company | ₹1.14 Cr (FY 2025) | ₹7,524 | 0.1% | -66.0% | New Delhi, Delhi, India | |
| Ytiliga Private Limited | ₹1.14 Cr (FY 2024) | 30.0% | Delhi, India |
To see the full peer comparison of Life Line Biotech Limited, buy the company report.
Auditor
Life Line Biotech Limited is audited by B. KAKKAR & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B. KAKKAR & CO. | FY 2023 | 029511N |
Shareholding
The shareholding of Life Line Biotech Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Life Line Biotech Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Oct 2007 | 10076752 | Bank of India | ₹4.5 Cr | Satisfied | |
| 12 Jul 2005 | 90051690 | State Bank of Bikaner & Jaipur | ₹1.05 Cr | Satisfied | |
| 10 Feb 1995 | 90046313 | State Bank of Bikaner & Jaipur | ₹7.5 Lakh | Satisfied | |
| 30 Mar 1994 | 90046136 | State Bank of Bikaner & Jaipur | ₹7 Lakh | Satisfied |
To see the full charge records of Life Line Biotech Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Life Line Biotech Limited has 22 court cases on record: 7 filed by Life Line Biotech, 15 filed against it. 2 cases are pending and 20 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 14 | 11 | 2 |
| High courts | 8 | 4 | 0 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Faridabad, Haryana | Cheque dishonour complaint | Filed against the company by Skymap Pharmaceuticals Pvt Ltd | Disposed |
| High Court of Delhi | Court case (CO.PET.) | Filed against the company by Skymap Pharmaceuticals Pvt. Ltd. | Disposed |
| District court, South East, Delhi | Civil suit | Filed against the company by Idbi Bank Ltd | Disposed |
| High Court of Delhi | Court case (CO.PET.) | Filed against the company by Lexus India Ltd | Disposed |
| District court, South, Delhi | Arbitration matter | Filed by the company against India Bulls Financial Services Ltd. | Disposed |
To see the full case history of Life Line Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Life Line Biotech Limited has 6 MSME Form 1 returns on record between 2022 and 2024, listing 65 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Square Vision India Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Rajdeep Pharmaceuticals | |||
| Siddhi Foils |
To see the full MSME payment records of Life Line Biotech Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Life Line Biotech Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
Life Line Biotech has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACL1154F1ZY | Delhi | Active | 01 Jul 2017 |
| 05AAACL1154F2Z1 | Uttarakhand | Active | 19 Sep 2019 |
To see the full GST registrations and return filing status of Life Line Biotech Limited, buy the company report.
Recent activity
Life Line Biotech Limited has 7 board changes on record since 2003: 5 appointments and 2 cessations. The latest: Esha Agarwal ceased to be Director on 01 Sep 2016.
8 earlier events are in the company report.
Frequently asked questions
Life Line Biotech is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 August 1986 (40+ years old) and is registered under CIN U24239DL1986PLC025119.
Life Line Biotech has 3 current directors:
- Satish Agarwal - Managing Director
- Santosh Agarwal - Whole-Time Director
- Kapil Sharma - Director
The latest financial statements of Life Line Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Life Line Biotech is 07AAACL1154F1ZY, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 05AAACL1154F2Z1 (Uttarakhand).
The CIN (Corporate Identification Number) of Life Line Biotech is U24239DL1986PLC025119. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Life Line Biotech has 22 court cases on record: 7 filed by the company and 15 filed against it. 2 are pending. Most are in the district courts.
Life Line Biotech was incorporated on 14 August 1986, making it 40+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Life Line Biotech by revenue are Osr Pharmaceuticals Private Limited, Pyramid Formulations Private Limited, Ytiliga Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Esha Agarwal ceased to be Director on 01 Sep 2016. Kapil Sharma was appointed as Director on 01 Sep 2016. Santosh Agarwal was appointed as Whole-Time Director on 12 Nov 2008. Life Line Biotech has 7 board changes on record in total.
Life Line Biotech has 6 MSME Form 1 returns on record between 2022 and 2024, listing 65 overdue payments to 14 micro and small suppliers. The latest return was filed on 29 Apr 2024.
Life Line Biotech can be reached through the website lifelinebiotech.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Life Line Biotech is at 51 Dsiidc Shed Okhla Industrial Area Phase – II New Delhi – 110020, Delhi, India – 110020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
